Protriptyline plasma levels and antidepressant response. 1977

J T Biggs, and V E Ziegler

Twenty-one depressed outpatients were treated for 4 wk with 20 mg/day of protriptyline. Protriptyline plasma in individuals after 4 wk ranged from 22 ng/ml to 167 ng/ml. There was a negative correlation (-0.50, less than 0.05) between the severity of depression measured by the Hamilton Rating Scale (HRS) and the wk 4 protriptyline concentration. Patients with plasma levels above 70 ng/ml (wk 4) had better outcomes measured by the HRS (p less than 0.05) and the Zung Self-Rating Depression Scale (p less than 0.05) and had greater percent decreases on both scales (p less than 0.05) during treatment than those with lower plasma levels. An upper limit to the therapeutic plasma level range beyond which response to treatment was less satisfactory was not demonstrated in this study.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011530 Protriptyline Tricyclic antidepressant similar in action and side effects to IMIPRAMINE. It may produce excitation. Protriptyline Hydrochloride,Vivactil,Hydrochloride, Protriptyline
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D003986 Dibenzocycloheptenes A family of tricyclic hydrocarbons whose members include many of the commonly used tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC).
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J T Biggs, and V E Ziegler
September 2017, European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,
J T Biggs, and V E Ziegler
January 1977, European journal of clinical pharmacology,
J T Biggs, and V E Ziegler
March 1968, The Medical letter on drugs and therapeutics,
J T Biggs, and V E Ziegler
August 1967, Drug and therapeutics bulletin,
J T Biggs, and V E Ziegler
October 1977, The Medical journal of Australia,
J T Biggs, and V E Ziegler
January 1964, Psychosomatics,
J T Biggs, and V E Ziegler
January 1967, The Journal of clinical pharmacology and the journal of new drugs,
J T Biggs, and V E Ziegler
September 1984, The Psychiatric clinics of North America,
J T Biggs, and V E Ziegler
June 1994, International clinical psychopharmacology,
J T Biggs, and V E Ziegler
June 2003, Human psychopharmacology,
Copied contents to your clipboard!